Data from Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7565446
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
708
Citations
7
h-index
6
i10-index
Zachary T. Britton is an academic researcher from Quality Biological. The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction. The author has an h-index of 7, co-authored 19 publications.
Click to start Chat